11β-HSD1抑制剂通过AMPK/mTOR自噬通路调节巨噬细胞极化减轻败血症诱导的心功能障碍

IF 2.6 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Zheng Zhang, Binghui Yin, Dongmei Zhu, Danying Wu, Min Huang, Suming Zhou
{"title":"11β-HSD1抑制剂通过AMPK/mTOR自噬通路调节巨噬细胞极化减轻败血症诱导的心功能障碍","authors":"Zheng Zhang, Binghui Yin, Dongmei Zhu, Danying Wu, Min Huang, Suming Zhou","doi":"10.1016/j.jjcc.2025.09.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Myocardial dysfunction is the most serious complication of sepsis. Sepsis-induced myocardial dysfunction (SIMD) is often associated with an excessive inflammatory response within the cardiac tissue. Targeted inhibition of the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) attenuates local tissue inflammatory responses. We investigated the efficacy of 11β-HSD1 blockade as a potential new treatment in SIMD.</p><p><strong>Methods: </strong>In mice, sepsis was established by intraperitoneally injecting lipopolysaccharide (LPS, 10 mg/kg). Subsequently, the effects of 11β-HSD1 selective inhibitor BVT.2733 administration on LPS-triggered cardiac dysfunction, macrophage infiltration, and spleen inflammation in mice were investigated. In in vitro studies, the macrophage cell line RAW264.7 was used to assess the effect and molecular mechanism of BVT.2733 (50 or 100 μM) on LPS-induced polarization and inflammation. Furthermore, the supernatant of macrophages was collected after intervention and co-cultured with the H9C2 cell line to assess cardiomyocyte apoptosis and injury.</p><p><strong>Results: </strong>The preventive administration of BVT.2733 can ameliorate cardiac dysfunction, M1 macrophage infiltration, and cardiac inflammation induced by LPS. The findings also demonstrated that BVT.2733 exhibited a mitigating effect on spleen pathological injury and inflammatory responses. Subsequently, BVT.2733 demonstrated the ability to inhibit M1 polarization of macrophages and attenuate inflammatory response in vitro. Meanwhile, our findings showed that BVT.2733 administration effectively mitigated inflammation and apoptosis in H9C2 cells in the proinflammatory environment produced by macrophages. Mechanistic studies revealed that BVT.2733 elevated autophagy levels by activating the AMPK/mTOR signaling pathway.</p><p><strong>Conclusion: </strong>The 11β-HSD1 selective inhibitor BVT.2733 demonstrates potential in ameliorating cardiac dysfunction and myocardial injury in septic mice induced by LPS. This beneficial effect is likely attributed to the modulation of macrophage polarization through the AMPK/mTOR autophagy pathway.</p>","PeriodicalId":15223,"journal":{"name":"Journal of cardiology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"11β-HSD1 inhibitor alleviates sepsis-induced cardiac dysfunction by regulating macrophage polarization via the AMPK/mTOR autophagy pathway.\",\"authors\":\"Zheng Zhang, Binghui Yin, Dongmei Zhu, Danying Wu, Min Huang, Suming Zhou\",\"doi\":\"10.1016/j.jjcc.2025.09.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Myocardial dysfunction is the most serious complication of sepsis. Sepsis-induced myocardial dysfunction (SIMD) is often associated with an excessive inflammatory response within the cardiac tissue. Targeted inhibition of the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) attenuates local tissue inflammatory responses. We investigated the efficacy of 11β-HSD1 blockade as a potential new treatment in SIMD.</p><p><strong>Methods: </strong>In mice, sepsis was established by intraperitoneally injecting lipopolysaccharide (LPS, 10 mg/kg). Subsequently, the effects of 11β-HSD1 selective inhibitor BVT.2733 administration on LPS-triggered cardiac dysfunction, macrophage infiltration, and spleen inflammation in mice were investigated. In in vitro studies, the macrophage cell line RAW264.7 was used to assess the effect and molecular mechanism of BVT.2733 (50 or 100 μM) on LPS-induced polarization and inflammation. Furthermore, the supernatant of macrophages was collected after intervention and co-cultured with the H9C2 cell line to assess cardiomyocyte apoptosis and injury.</p><p><strong>Results: </strong>The preventive administration of BVT.2733 can ameliorate cardiac dysfunction, M1 macrophage infiltration, and cardiac inflammation induced by LPS. The findings also demonstrated that BVT.2733 exhibited a mitigating effect on spleen pathological injury and inflammatory responses. Subsequently, BVT.2733 demonstrated the ability to inhibit M1 polarization of macrophages and attenuate inflammatory response in vitro. Meanwhile, our findings showed that BVT.2733 administration effectively mitigated inflammation and apoptosis in H9C2 cells in the proinflammatory environment produced by macrophages. Mechanistic studies revealed that BVT.2733 elevated autophagy levels by activating the AMPK/mTOR signaling pathway.</p><p><strong>Conclusion: </strong>The 11β-HSD1 selective inhibitor BVT.2733 demonstrates potential in ameliorating cardiac dysfunction and myocardial injury in septic mice induced by LPS. This beneficial effect is likely attributed to the modulation of macrophage polarization through the AMPK/mTOR autophagy pathway.</p>\",\"PeriodicalId\":15223,\"journal\":{\"name\":\"Journal of cardiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jjcc.2025.09.003\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jjcc.2025.09.003","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

目的:心肌功能障碍是脓毒症最严重的并发症。脓毒症引起的心肌功能障碍(SIMD)通常与心脏组织内过度的炎症反应有关。靶向抑制11β-羟基类固醇脱氢酶1型(11β-HSD1)活性可减轻局部组织炎症反应。我们研究了11β-HSD1阻断作为SIMD潜在的新治疗方法的有效性。方法:小鼠腹腔注射脂多糖(LPS, 10 mg/kg)建立脓毒症。随后,研究11β-HSD1选择性抑制剂BVT.2733对lps诱发小鼠心功能障碍、巨噬细胞浸润和脾脏炎症的影响。体外实验采用巨噬细胞系RAW264.7研究BVT.2733 (50 μM或100 μM)对lps诱导的极化和炎症的影响及其分子机制。干预后收集巨噬细胞上清,与H9C2细胞系共培养,评估心肌细胞凋亡和损伤情况。结果:预防性给药BVT.2733可改善LPS诱导的心功能障碍、M1巨噬细胞浸润和心脏炎症。结果还表明,BVT.2733对脾脏病理损伤和炎症反应具有减轻作用。随后,BVT.2733在体外表现出抑制巨噬细胞M1极化和减轻炎症反应的能力。同时,我们的研究结果表明,在巨噬细胞产生的促炎环境中,BVT.2733给药可有效减轻H9C2细胞的炎症和凋亡。机制研究表明,BVT.2733通过激活AMPK/mTOR信号通路来提高自噬水平。结论:11β-HSD1选择性抑制剂BVT.2733具有改善LPS致脓毒症小鼠心功能障碍和心肌损伤的作用。这种有益作用可能归因于通过AMPK/mTOR自噬途径调节巨噬细胞极化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
11β-HSD1 inhibitor alleviates sepsis-induced cardiac dysfunction by regulating macrophage polarization via the AMPK/mTOR autophagy pathway.

Objectives: Myocardial dysfunction is the most serious complication of sepsis. Sepsis-induced myocardial dysfunction (SIMD) is often associated with an excessive inflammatory response within the cardiac tissue. Targeted inhibition of the activity of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) attenuates local tissue inflammatory responses. We investigated the efficacy of 11β-HSD1 blockade as a potential new treatment in SIMD.

Methods: In mice, sepsis was established by intraperitoneally injecting lipopolysaccharide (LPS, 10 mg/kg). Subsequently, the effects of 11β-HSD1 selective inhibitor BVT.2733 administration on LPS-triggered cardiac dysfunction, macrophage infiltration, and spleen inflammation in mice were investigated. In in vitro studies, the macrophage cell line RAW264.7 was used to assess the effect and molecular mechanism of BVT.2733 (50 or 100 μM) on LPS-induced polarization and inflammation. Furthermore, the supernatant of macrophages was collected after intervention and co-cultured with the H9C2 cell line to assess cardiomyocyte apoptosis and injury.

Results: The preventive administration of BVT.2733 can ameliorate cardiac dysfunction, M1 macrophage infiltration, and cardiac inflammation induced by LPS. The findings also demonstrated that BVT.2733 exhibited a mitigating effect on spleen pathological injury and inflammatory responses. Subsequently, BVT.2733 demonstrated the ability to inhibit M1 polarization of macrophages and attenuate inflammatory response in vitro. Meanwhile, our findings showed that BVT.2733 administration effectively mitigated inflammation and apoptosis in H9C2 cells in the proinflammatory environment produced by macrophages. Mechanistic studies revealed that BVT.2733 elevated autophagy levels by activating the AMPK/mTOR signaling pathway.

Conclusion: The 11β-HSD1 selective inhibitor BVT.2733 demonstrates potential in ameliorating cardiac dysfunction and myocardial injury in septic mice induced by LPS. This beneficial effect is likely attributed to the modulation of macrophage polarization through the AMPK/mTOR autophagy pathway.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of cardiology
Journal of cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.90
自引率
8.00%
发文量
202
审稿时长
29 days
期刊介绍: The official journal of the Japanese College of Cardiology is an international, English language, peer-reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信